Wu Y - Search Results

1

Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug.

Rais R, Lemberg KM, Tenora L, Arwood ML, Pal A, Alt J, Wu Y, Lam J, Aguilar JMH, Zhao L, Peters DE, Tallon C, Pandey R, Thomas AG, Dash RP, Seiwert T, Majer P, Leone RD, Powell JD, Slusher BS. Rais R, et al. Among authors: wu y. Sci Adv. 2022 Nov 18;8(46):eabq5925. doi: 10.1126/sciadv.abq5925. Epub 2022 Nov 16. Sci Adv. 2022. PMID: 36383674 Free PMC article.

2

Enantiospecificity of glutamate carboxypeptidase II inhibition.

Tsukamoto T, Majer P, Vitharana D, Ni C, Hin B, Lu XC, Thomas AG, Wozniak KM, Calvin DC, Wu Y, Slusher BS, Scarpetti D, Bonneville GW. Tsukamoto T, et al. Among authors: wu y. J Med Chem. 2005 Apr 7;48(7):2319-24. doi: 10.1021/jm049258g. J Med Chem. 2005. PMID: 15801825

3

DPP IV inhibitor blocks mescaline-induced scratching and amphetamine-induced hyperactivity in mice.

Lautar SL, Rojas C, Slusher BS, Wozniak KM, Wu Y, Thomas AG, Waldon D, Li W, Ferraris D, Belyakov S. Lautar SL, et al. Among authors: wu y. Brain Res. 2005 Jun 28;1048(1-2):177-84. doi: 10.1016/j.brainres.2005.04.069. Brain Res. 2005. PMID: 15925329

4

Glutamate carboxypeptidase II (NAALADase) inhibition as a novel therapeutic strategy.

Thomas AG, Wozniak KM, Tsukamoto T, Calvin D, Wu Y, Rojas C, Vornov J, Slusher BS. Thomas AG, et al. Among authors: wu y. Adv Exp Med Biol. 2006;576:327-37; discussion 361-3. doi: 10.1007/0-387-30172-0_24. Adv Exp Med Biol. 2006. PMID: 16802724 Review.

5

Comparison of neuropathy-inducing effects of eribulin mesylate, paclitaxel, and ixabepilone in mice.

Wozniak KM, Nomoto K, Lapidus RG, Wu Y, Carozzi V, Cavaletti G, Hayakawa K, Hosokawa S, Towle MJ, Littlefield BA, Slusher BS. Wozniak KM, et al. Among authors: wu y. Cancer Res. 2011 Jun 1;71(11):3952-62. doi: 10.1158/0008-5472.CAN-10-4184. Epub 2011 Apr 15. Cancer Res. 2011. PMID: 21498637

6

Development of a high-throughput method for the determination of pharmacological levels of plasma D-serine.

Alt J, Rojas C, Wozniak K, Wu Y, Ferraris D, Tsukamoto T, Slusher B. Alt J, et al. Among authors: wu y. Anal Biochem. 2011 Dec 15;419(2):106-9. doi: 10.1016/j.ab.2011.08.018. Epub 2011 Aug 16. Anal Biochem. 2011. PMID: 21889486 Free PMC article.

7

The role of glutamate signaling in pain processes and its regulation by GCP II inhibition.

Wozniak KM, Rojas C, Wu Y, Slusher BS. Wozniak KM, et al. Among authors: wu y. Curr Med Chem. 2012;19(9):1323-34. doi: 10.2174/092986712799462630. Curr Med Chem. 2012. PMID: 22304711 Review.

8

Pharmacokinetics of oral D-serine in D-amino acid oxidase knockout mice.

Rais R, Thomas AG, Wozniak K, Wu Y, Jaaro-Peled H, Sawa A, Strick CA, Engle SJ, Brandon NJ, Rojas C, Slusher BS, Tsukamoto T. Rais R, et al. Among authors: wu y. Drug Metab Dispos. 2012 Nov;40(11):2067-73. doi: 10.1124/dmd.112.046482. Epub 2012 Jul 26. Drug Metab Dispos. 2012. PMID: 22837388 Free PMC article.

9

The orally active glutamate carboxypeptidase II inhibitor E2072 exhibits sustained nerve exposure and attenuates peripheral neuropathy.

Wozniak KM, Wu Y, Vornov JJ, Lapidus R, Rais R, Rojas C, Tsukamoto T, Slusher BS. Wozniak KM, et al. Among authors: wu y. J Pharmacol Exp Ther. 2012 Dec;343(3):746-54. doi: 10.1124/jpet.112.197665. Epub 2012 Sep 17. J Pharmacol Exp Ther. 2012. PMID: 22988061

10

Neuropathy-inducing effects of eribulin mesylate versus paclitaxel in mice with preexisting neuropathy.

Wozniak KM, Wu Y, Farah MH, Littlefield BA, Nomoto K, Slusher BS. Wozniak KM, et al. Among authors: wu y. Neurotox Res. 2013 Oct;24(3):338-44. doi: 10.1007/s12640-013-9394-3. Epub 2013 Apr 30. Neurotox Res. 2013. PMID: 23637052 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

78,253 results

Search Page